// App-Quantinova.ai

: Risk Factors for Secondary Cancer in a Case-Control Study on 1,259 Patients with Myeloproliferative Neoplasms

Researchers

Presenter

  • Tiziano Barbui

Principal Investigators

  • Arianna Masciulli

  • Alessandra Carobbio

  • Francesca Palandri

  • Nicola Vianelli

  • Valerio De Stefano

  • Silvia Betti

  • Ambra Di Veroli

  • Alessandra Iurlo

  • Daniele Cattaneo

  • Federica Delaini

  • Massimiliano Bonifacio

  • Luigi Scaffidi

  • Andrea Patriarca

  • Elisa Rumi

  • Clemency Stephenson

  • Paola Guglielmelli

  • Elena Maria Elli

  • Palova Miroslava

  • Laura Bertolotti

  • Daniel Erez

  • Montse Gomez

  • Kai Wille

  • Manuel Prez-Encinas

  • Francesca Lunghi

  • Anna Angola Figueras

  • Maria Laura Fox

  • Eloise Beggiato

  • Giulia Benevolo

  • Giuseppe Carli

  • Rossella Rosari Cacciola

  • Mary Frances McMullin

  • Alessia Tieghi

  • Valle Recanses Flores

  • Monia Marchetti

  • Martin Griesshammer

  • Alberto Alvarez-Larran

  • Alessandro M. Vannucchi

  • Guido Finazzi

Medical Centers

  • FROM Research Foundation,ASST Papa Giovanni XXIII,Bergamo, Italy,Italy

  • Institute of Hematology “L. and A. Seràgnoli”, Sant’Orsola-Malpighi University Hospital,Bologna,Italy

  • Istituto Ematologia, Universit Cattolica del Sacro Cuore Roma, Roma, Italy

  • Institute of Hematology, Catholic University, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy

  • Rete laziale MPN, Roma, Italy

  • Oncohematology Division, Fondazione IRCCS Ospedale Maggiore Policlinico, Milan, Italy

  • Oncohematology Division, Fondazione IRCCS Ospedale Maggiore Policlinico, Milan, Italy

  • Hematology and Bone Marrow Transplant Unit, University of Milan, ASST Papa Giovanni XXIII, Bergamo, Italy

  • Department of Medicine, Section of Hematology, University of Verona, Verona, Italy

  • Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy, Novara, Italy

  • Department of Clinical Medicine 3, University of Padova, Padova, Italy

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • CRIMM, Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy

  • Hematology Division,Ospedale San Gerardo, ASST Monza,Monza,Italy

  • Dept. of Hematology/Oncology, Charles University Hospital, Pilsen, Czech Republic,

  • Hematology Division, Azienda Ospedaliera S. Croce e Carle Cuneo,Cuneo,Italy

  • Hematology Institute and Blood Bank, Meir Medical Center, Kfar Saba, and Sackler School of Medicine Tel Aviv University, Tel Aviv, Israel

  • Hematology Department, Hospital Clinico Universitario de Valencia, Valencia,

  • University Clinic for Hematology and Oncology Minden, University of Bochum, Bochum, Germany

  • Pharmacy Departmente. Hospital Clinico Universitario de Santiago de Compostela, Santiago De Compostela, Spain

  • Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy

  • Medical Oncology, Hospital del Mar, Barcelona, Spain

  • Medical Oncology Department, Hospital Universitario Vall D'Hebron, Barcelona, Spain

  • Unit of Hematology, Department of Oncology, University of Torino, Torino, Italy

  • Department of Hematology, S. Bortolo Hospital, Vicenza, Vicenza, Italy

  • HAEMOSTASIS UNIT, Department of Clinical and Experimental Medicine, University of Catania, 'Policlinico-Vittorio Emanuele' Hospital,Catania,Italy

  • Queen's University Belfast, Belfast, United Kingdom

  • Pathology Unit, Azienda Unita' Sanitaria Locale IRCCS di Reggio Emilia, Reggio Emilia, Italy

  • Hematology Division, Hospital Universitario Miguel Servet (HUMS), Zaragoza, Spain

  • Medical Oncology Cardinal Massaia Hospital, Asti, Italy

  • Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain,

  • CRIMM-Center of Research and Innovation of Myeloproliferative Neoplasms,Azienda Ospedaliero-Universitaria Careggi,Florence,Italy;Department of Experimental and Clinical Medicine,University of Florence,Florence,Italy

  • Rheumatology Unit, Papa Giovanni XXIII Hospital, Bergamo, Italy

Locations

  • Italy

  • United Kingdom

  • Czech Republic

  • Israel

  • Spain

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved